The efficacy of bevacizumab in diabetic macular oedema in a 12-month follow-up

Agnieszka Jamrozy-Witkowska; Iwona Grabska-Liberek; Katarzyna Skonieczna

Full text

4/2014 vol. 116

Original paper

The efficacy of bevacizumab in diabetic macular oedema in a 12-month follow-up

Agnieszka Jamrozy-Witkowska ¹

,

Iwona Grabska-Liberek ¹

,

Katarzyna Skonieczna ¹

Ophthalmology Department the Medical Centre of Postgraduate Education in Warsaw

Data publikacji online: 2021/05/28

Article file

1KO_04_2014_JAMROZY_THE_EFFIACY.pdf

AMA

Jamrozy-Witkowska A, Grabska-Liberek I, Skonieczna K. The efficacy of bevacizumab in diabetic macular oedema in a 12-month follow-up. Klinika Oczna / Acta Ophthalmologica Polonica. 2014;116(4):237-241.

APA

Jamrozy-Witkowska, A., Grabska-Liberek, I., & Skonieczna, K. (2014). The efficacy of bevacizumab in diabetic macular oedema in a 12-month follow-up. Klinika Oczna / Acta Ophthalmologica Polonica, 116(4), 237-241.

Chicago

Jamrozy-Witkowska, Agnieszka, Iwona Grabska-Liberek, and Katarzyna Skonieczna. 2014. "The efficacy of bevacizumab in diabetic macular oedema in a 12-month follow-up". Klinika Oczna / Acta Ophthalmologica Polonica 116 (4): 237-241.

Harvard

Jamrozy-Witkowska, A., Grabska-Liberek, I., and Skonieczna, K. (2014). The efficacy of bevacizumab in diabetic macular oedema in a 12-month follow-up. Klinika Oczna / Acta Ophthalmologica Polonica, 116(4), pp.237-241.

MLA

Jamrozy-Witkowska, Agnieszka et al. "The efficacy of bevacizumab in diabetic macular oedema in a 12-month follow-up." Klinika Oczna / Acta Ophthalmologica Polonica, vol. 116, no. 4, 2014, pp. 237-241.

Vancouver

Jamrozy-Witkowska A, Grabska-Liberek I, Skonieczna K. The efficacy of bevacizumab in diabetic macular oedema in a 12-month follow-up. Klinika Oczna / Acta Ophthalmologica Polonica. 2014;116(4):237-241.

SUBMIT YOUR PAPER

Share

Integrated with

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications